• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

韩国某单一中心的幽门螺杆菌菌株的抗生素耐药性及其对幽门螺杆菌根除率的影响。

Antibiotic resistance in Helicobacter pylori strains and its effect on H. pylori eradication rates in a single center in Korea.

机构信息

Department of Laboratory Medicine, Yongin Severance Hospital, Yongin, Korea.

出版信息

Ann Lab Med. 2013 Nov;33(6):415-9. doi: 10.3343/alm.2013.33.6.415. Epub 2013 Oct 17.

DOI:10.3343/alm.2013.33.6.415
PMID:24205490
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3819440/
Abstract

BACKGROUND

Clarithromycin, amoxicillin, metronidazole, tetracycline, and levofloxacin have been commonly used for the eradication of Helicobacter pylori. We compared the change in antibiotic resistance of H. pylori strains during two separate periods and investigated the effect of antibiotic resistance on H. pylori eradication.

METHODS

H. pylori strains were isolated from 71 patients between 2009 and 2010 and from 94 patients between 2011 and 2012. The distribution of minimal inhibitory concentration (MIC) of 5 antibiotics was assessed using the agar dilution method, and H. pylori eradication based on the antimicrobial susceptibility of the isolates was investigated retrospectively.

RESULTS

Antibiotic resistance rate against clarithromycin, amoxicillin, tetracycline, metronidazole, and levofloxacin for the 2009-2010 isolates were 7.0% (5/71), 2.8% (2/71), 0% (0/71), 45.1% (32/71), and 26.8% (19/71), respectively, and for the 2011-2012 isolates were 16.0% (15/94), 2.1% (2/94), 0% (0/94), 56.3% (53/94), and 22.3% (21/94), respectively. Multi-drug resistance for 2 or more antibiotics increased slightly from 16.9% (12/71) in the 2009-2010 isolates to 23.4% (22/94) in the 2011-2012 isolates. In follow-up testing of 66 patients, first-line treatment successfully eradicated H. pylori in 50 patients (75.8%) and failed in 4 of 7 patients (57.1%) in a clarithromycin-resistant and amoxicillin-susceptible group.

CONCLUSIONS

We observed an increase in resistance to clarithromycin and an overall increase in multi-drug resistance during the 2 study periods. The effectiveness of the eradication regimen was low with combinations of clarithromycin and amoxicillin, particularly in the clarithromycin-resistant group. Thus, eradication of H. pylori depends upon periodic monitoring of antimicrobial susceptibility.

摘要

背景

克拉霉素、阿莫西林、甲硝唑、四环素和左氧氟沙星常用于根除幽门螺杆菌。我们比较了两个不同时期幽门螺杆菌菌株的抗生素耐药性变化,并研究了抗生素耐药性对幽门螺杆菌根除的影响。

方法

从 2009 年至 2010 年的 71 名患者和 2011 年至 2012 年的 94 名患者中分离出幽门螺杆菌菌株。采用琼脂稀释法评估 5 种抗生素的最小抑菌浓度(MIC)分布,根据分离物的抗菌药敏性回顾性调查幽门螺杆菌根除情况。

结果

2009-2010 年分离株对克拉霉素、阿莫西林、四环素、甲硝唑和左氧氟沙星的抗生素耐药率分别为 7.0%(5/71)、2.8%(2/71)、0%(0/71)、45.1%(32/71)和 26.8%(19/71),2011-2012 年分离株分别为 16.0%(15/94)、2.1%(2/94)、0%(0/94)、56.3%(53/94)和 22.3%(21/94)。2 种或 2 种以上抗生素的多药耐药性略有增加,从 2009-2010 年分离株的 16.9%(12/71)增加到 2011-2012 年分离株的 23.4%(22/94)。在对 66 名患者的随访检测中,克拉霉素耐药且阿莫西林敏感的 7 名患者中有 4 名(57.1%)治疗失败,而一线治疗成功根除幽门螺杆菌的患者有 50 名(75.8%)。

结论

我们观察到在两个研究期间,对克拉霉素的耐药性增加,并且总体上多药耐药性增加。克拉霉素和阿莫西林联合用药的根除方案效果不佳,尤其是在克拉霉素耐药组。因此,幽门螺杆菌的根除取决于定期监测抗菌药物敏感性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ecd/3819440/b69c6a13c505/alm-33-415-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ecd/3819440/dbd7e4fd37cb/alm-33-415-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ecd/3819440/b69c6a13c505/alm-33-415-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ecd/3819440/dbd7e4fd37cb/alm-33-415-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ecd/3819440/b69c6a13c505/alm-33-415-g002.jpg

相似文献

1
Antibiotic resistance in Helicobacter pylori strains and its effect on H. pylori eradication rates in a single center in Korea.韩国某单一中心的幽门螺杆菌菌株的抗生素耐药性及其对幽门螺杆菌根除率的影响。
Ann Lab Med. 2013 Nov;33(6):415-9. doi: 10.3343/alm.2013.33.6.415. Epub 2013 Oct 17.
2
Primary and secondary antibiotic resistance of Helicobacter pylori in Korea from 2003 to 2018.韩国 2003 年至 2018 年幽门螺杆菌的初级和次级抗生素耐药性。
Helicobacter. 2019 Dec;24(6):e12660. doi: 10.1111/hel.12660. Epub 2019 Sep 11.
3
The effect of previous eradication failure on antibiotic resistance of Helicobacter pylori: A retrospective study over 8 years in Beijing.既往根除失败对幽门螺杆菌耐药性的影响:北京 8 年回顾性研究。
Helicobacter. 2021 Aug;26(4):e12804. doi: 10.1111/hel.12804. Epub 2021 Apr 16.
4
[Changing patterns of antibiotic resistance of Helicobacter pylori in patients with peptic ulcer disease].[消化性溃疡病患者幽门螺杆菌抗生素耐药模式的变化]
Korean J Gastroenterol. 2007 Dec;50(6):356-62.
5
ANTIBIOTIC RESISTANCE SURVEILLANCE OF HELICOBACTER PYLORI AT THE BIOBÍO REGION (CHILE) IN A DECADE.十年间智利比奥比奥地区幽门螺杆菌的抗生素耐药性监测
Arq Gastroenterol. 2019 Oct-Dec;56(4):361-366. doi: 10.1590/S0004-2803.201900000-72.
6
Broad spectrum resistance in Helicobacter pylori isolated from gastric biopsies of patients with dyspepsia in Cameroon and efflux-mediated multiresistance detection in MDR isolates.在喀麦隆消化不良患者的胃活检中分离出的幽门螺杆菌的广谱耐药性和 MDR 分离株中流出介导的多药耐药性检测。
BMC Infect Dis. 2019 Oct 22;19(1):880. doi: 10.1186/s12879-019-4536-8.
7
Institutional difference of antibiotic resistance of Helicobacter pylori strains in Korea.韩国幽门螺杆菌菌株抗生素耐药性的机构差异。
J Clin Gastroenterol. 2006 Sep;40(8):683-7. doi: 10.1097/00004836-200609000-00004.
8
Five-year sequential changes in secondary antibiotic resistance of Helicobacter pylori in Taiwan.台湾幽门螺杆菌继发性抗生素耐药性的五年连续变化
World J Gastroenterol. 2015 Oct 7;21(37):10669-74. doi: 10.3748/wjg.v21.i37.10669.
9
Dynamics of antimicrobial resistance of Helicobacter pylori isolates in the Smolensk region of Russian Federation.俄罗斯联邦斯摩棱斯克地区幽门螺杆菌分离株的抗菌药物耐药性动态。
Helicobacter. 2018 Dec;23(6):e12545. doi: 10.1111/hel.12545. Epub 2018 Oct 16.
10
Nationwide antibiotic resistance mapping of Helicobacter pylori in Korea: A prospective multicenter study.韩国全国范围内幽门螺杆菌抗生素耐药性的绘图:一项前瞻性多中心研究。
Helicobacter. 2019 Aug;24(4):e12592. doi: 10.1111/hel.12592. Epub 2019 May 20.

引用本文的文献

1
Antibiotic Resistance of Helicobacter pylori: Current Trends in Daegu-Kyungpook.幽门螺杆菌的抗生素耐药性:大邱-庆尚北道的当前趋势
Korean J Helicobacter Up Gastrointest Res. 2025 Jun;25(2):146-151. doi: 10.7704/kjhugr.2025.0010. Epub 2025 Jun 4.
2
Isolation and Antibiotic Susceptibility Testing Using Rapidly Frozen Biopsy Samples.使用快速冷冻活检样本进行分离培养及药敏试验
Korean J Helicobacter Up Gastrointest Res. 2024 Dec;24(4):360-364. doi: 10.7704/kjhugr.2024.0063. Epub 2024 Dec 4.
3
An eco-friendly liquid chromatographic analysis of the triple therapy protocol of amoxicillin, metronidazole and vonoprazan for H. Pylori eradication: application to combined dosage forms and simulated gastric fluid.

本文引用的文献

1
[Regional difference of antibiotic resistance of helicobacter pylori strains in Korea].[韩国幽门螺杆菌菌株抗生素耐药性的区域差异]
Korean J Gastroenterol. 2011 Apr;57(4):221-9. doi: 10.4166/kjg.2011.57.4.221.
2
Change in antibiotic resistance of Helicobacter pylori strains and the effect of A2143G point mutation of 23S rRNA on the eradication of H. pylori in a single center of Korea.韩国单中心研究显示幽门螺杆菌菌株的抗生素耐药性变化及 23S rRNA 基因 A2143G 点突变对幽门螺杆菌根除的影响。
J Clin Gastroenterol. 2010 Sep;44(8):536-43. doi: 10.1097/MCG.0b013e3181d04592.
3
[Diagnosis and treatment guidelines for Helicobacter pylori infection in Korea].
阿莫西林、甲硝唑和沃克三联疗法根除幽门螺杆菌的环保液相色谱分析:在复方制剂及模拟胃液中的应用
BMC Chem. 2024 May 30;18(1):106. doi: 10.1186/s13065-024-01210-6.
4
Quantitative multiplex real-time polymerase chain reaction assay for the detection of Helicobacter pylori and clarithromycin resistance.定量多重实时聚合酶链反应检测幽门螺杆菌和克拉霉素耐药性。
BMC Microbiol. 2023 May 27;23(1):155. doi: 10.1186/s12866-023-02868-z.
5
The prevalence of clarithromycin-resistant isolates: a systematic review and meta-analysis.克拉霉素耐药分离株的流行率:系统评价和荟萃分析。
PeerJ. 2023 Mar 30;11:e15121. doi: 10.7717/peerj.15121. eCollection 2023.
6
The Efficacy, Safety, and Tolerability of Levofloxacin Quadruple Therapy for Eradication: A Randomized, Double-Blind Clinical Trial.左氧氟沙星四联疗法根除幽门螺杆菌的疗效、安全性及耐受性:一项随机双盲临床试验
Evid Based Complement Alternat Med. 2022 Dec 6;2022:9794901. doi: 10.1155/2022/9794901. eCollection 2022.
7
Real-Time Polymerase Chain Reaction for the Detection of and Clarithromycin Resistance.实时聚合酶链反应检测和克拉霉素耐药性。
Gut Liver. 2023 May 15;17(3):375-381. doi: 10.5009/gnl220076. Epub 2022 Jul 20.
8
Two New Fatty Acid Derivatives, Omphalotols A and B and Anti- Fatty Acid Derivatives from Poisonous Mushroom .两种新的脂肪酸衍生物,来自有毒蘑菇的脐孢菌素A和B以及抗脂肪酸衍生物。
Pharmaceuticals (Basel). 2022 Jan 25;15(2):139. doi: 10.3390/ph15020139.
9
Improving Antibacterial Activity of a HtrA Protease Inhibitor JO146 against : A Novel Approach Using Microfluidics-Engineered PLGA Nanoparticles.提高HtrA蛋白酶抑制剂JO146的抗菌活性:一种使用微流控工程化聚乳酸-羟基乙酸共聚物纳米颗粒的新方法。
Pharmaceutics. 2022 Feb 1;14(2):348. doi: 10.3390/pharmaceutics14020348.
10
(Licorice): A Comprehensive Review on Its Phytochemistry, Biological Activities, Clinical Evidence and Toxicology.(甘草):关于其植物化学、生物活性、临床证据和毒理学的综合综述
Plants (Basel). 2021 Dec 14;10(12):2751. doi: 10.3390/plants10122751.
[韩国幽门螺杆菌感染的诊断和治疗指南]
Korean J Gastroenterol. 2009 Nov;54(5):269-78. doi: 10.4166/kjg.2009.54.5.269.
4
[Eradication rate of first-line and second-line therapy for Helicobacter pylori infection, and reinfection rate after successful eradication].[幽门螺杆菌感染一线和二线治疗的根除率以及成功根除后的再感染率]
Korean J Gastroenterol. 2007 Sep;50(3):170-5.
5
Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report.幽门螺杆菌感染管理的当前概念:马斯特里赫特III共识报告。
Gut. 2007 Jun;56(6):772-81. doi: 10.1136/gut.2006.101634. Epub 2006 Dec 14.
6
[The trend of eradication rates of first-line triple therapy for Helicobacter pylori infection: single center experience for recent eight years].[幽门螺杆菌感染一线三联疗法根除率的趋势:近八年单中心经验]
Korean J Gastroenterol. 2006 Sep;48(3):156-61.
7
Institutional difference of antibiotic resistance of Helicobacter pylori strains in Korea.韩国幽门螺杆菌菌株抗生素耐药性的机构差异。
J Clin Gastroenterol. 2006 Sep;40(8):683-7. doi: 10.1097/00004836-200609000-00004.
8
Distribution of fluoroquinolone MICs in Helicobacter pylori strains from Korean patients.韩国患者幽门螺杆菌菌株中氟喹诺酮类药物最低抑菌浓度的分布情况。
J Antimicrob Chemother. 2005 Nov;56(5):965-7. doi: 10.1093/jac/dki334. Epub 2005 Sep 13.
9
[Antibiotic resistance of Helicobacter pylori isolated from Korean patients in 2003].
Korean J Gastroenterol. 2004 Sep;44(3):126-35.
10
Changing pattern of antimicrobial resistance of Helicobacter pylori in Korean patients with peptic ulcer diseases.
J Gastroenterol. 2003;38(5):436-41. doi: 10.1007/s00535-002-1079-2.